TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
BioInvent International AB
Closing information (x1000 NOK)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 308,487 | 18,904 | 154,387 |
Financial expenses | 751 | 699 | 1,555 |
Earnings before taxes | -40,204 | -271,545 | -79,967 |
EBITDA | -48,167 | -271,453 | -79,067 |
Total assets | 1,619,605 | 1,411,450 | 840,847 |
Current assets | 1,025,428 | 1,088,367 | 809,842 |
Current liabilities | 82,596 | 57,335 | 56,056 |
Equity capital | 1,519,251 | 1,333,116 | 778,891 |
- share capital | 12,291 | 11,404 | 82,501 |
Employees (average) | 89 | 79 | 72 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 93.8% | 94.5% | 92.6% |
Turnover per employee | 3,466 | 239 | 2,144 |
Profit as a percentage of turnover | -13.0% | -1436.4% | -51.8% |
Return on assets (ROA) | -2.4% | -19.2% | -9.3% |
Current ratio | 1241.5% | 1898.3% | 1444.7% |
Return on equity (ROE) | -2.6% | -20.4% | -10.3% |
Change turnover | 290,151 | -124,817 | 56,185 |
Change turnover % | 1582% | -87% | 57% |
Chg. No. of employees | 10 | 7 | 4 |
Chg. No. of employees % | 13% | 10% | 6% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.